Registry for patients undergoing percutaneous transluminal angioplasty

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects clinical data from patients who are undergoing percutaneous transluminal angioplasty (PTA), a minimally invasive procedure used to treat peripheral artery disease. The study is observational and aims to systematically assess the characteristics and outcomes of these patients. By gathering this data, researchers hope to better understand the effectiveness and safety of PTA in various patient populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing PTA

Exclusion Criteria:

* \< 18 years

Where it's running

• Division of Cardiology, Pulmonary Disease and Vascular Medicine
  Düsseldorf, Germany Recruiting

Study contacts

• Principal investigator: Christian Heiss, MD — Division of Cardiology, Pulmonary Disease and Vascular Medicine
• Study coordinator: Christian Heiss, MD
• Email: christian.heiss@med.uni-duesseldorf.de
• Phone: +49 211 8118800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Skin microcirculation monitoring in people with lower limb atherosclerosis having angioplasty

  This tests whether the non-invasive ODI-Tech device can track changes in skin blood flow in adults with lower limb atherosclerosis who are having percutaneous transluminal angioplasty.

  Recruiting ODI Medical AS · Oslo · NCT07312383

• Multimodal Movement Tracking in CIDP

  This study tests whether high-resolution whole-body motion data from wearable sensors can reveal changes in motor function for adults with CIDP undergoing treatment.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf, North Rhine-Westphalia · NCT07882797

• How external factors affect 2D-NIRS tissue oxygenation measurements in healthy volunteers

  This study tests how things like temperature, activity, caffeine, and nicotine influence 2D-NIRS measurements of tissue oxygenation in healthy adults.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf · NCT07854431

• Liquid biopsy to detect tumor cells and tumor DNA in people with paraneoplastic neurological syndromes.

  This project tests whether a large blood collection (diagnostic leukapheresis) plus sensitive lab tests can find circulating tumor cells or tumor DNA in adults with paraneoplastic neurological syndromes, whether or not a tumor is already known.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf · NCT07491328

• Sleep problems, fatigue, and thinking ability in people with MS

  We will try to see if sleep problems explain why adults with MS feel very tired and have trouble thinking.

  Recruiting at 2 sites Heinrich-Heine University, Duesseldorf · Düsseldorf and 1 other locations · NCT07426991

• Metabolic deterioration after heart transplant determines outcomes

  We'll test whether worsening cardiac and systemic metabolism after a heart transplant predicts heart function and long-term survival in adult transplant recipients.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf, North Rhine-Westphalia · NCT07372820

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.